Report Detail

Request for Sample of this report

Chemical & Material Global Bifidobacterium Longum Subsp. Infantis M-63 Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4646478
    • |
  • 09 November, 2025
    • |
  • Global
    • |
  • 147 Pages
    • |
  • GIR
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Bifidobacterium Longum Subsp. Infantis M-63 market size was valued at US$ 46 million in 2024 and is forecast to a readjusted size of USD 69.1 million by 2031 with a CAGR of 6.1% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Bifidobacterium Longum Subsp. Infantis M-63 is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.
This report is a detailed and comprehensive analysis for global Bifidobacterium Longum Subsp. Infantis M-63 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Bifidobacterium Longum Subsp. Infantis M-63 market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Bifidobacterium Longum Subsp. Infantis M-63 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Bifidobacterium Longum Subsp. Infantis M-63 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Bifidobacterium Longum Subsp. Infantis M-63 market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bifidobacterium Longum Subsp. Infantis M-63
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bifidobacterium Longum Subsp. Infantis M-63 market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mitushi Biopharma, Fengchen Group, Jiangsu Wecare Biotechnology Co., Ltd., Shenzhen Lefu Biotechnology Co., Ltd., Hebei Hongtao Bioengineering Co., Ltd., Shandong Junle Biotechnology Co., Ltd., Shandong Xinxiong Biotechnology Co., Ltd., Newgen Biotech, Pharm-Rx, Rajvi Enterprise, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Bifidobacterium Longum Subsp. Infantis M-63 market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
0-50 billion CFU/g
50-100 billion CFU/g
＞100 billion CFU/g
Market segment by Application
Food Additives
Medicines and Supplements
Feed Additives
Others
Major players covered
Mitushi Biopharma
Fengchen Group
Jiangsu Wecare Biotechnology Co., Ltd.
Shenzhen Lefu Biotechnology Co., Ltd.
Hebei Hongtao Bioengineering Co., Ltd.
Shandong Junle Biotechnology Co., Ltd.
Shandong Xinxiong Biotechnology Co., Ltd.
Newgen Biotech
Pharm-Rx
Rajvi Enterprise
Shandong Pingao Pharmaceutical Co., Ltd.
Shaanxi Chenming Biotechnology Co., Ltd.
Xi'an Minglang Biotechnology Co., Ltd.
Jiahe Biotechnology (Shanxi) Co., Ltd.
Shaanxi Ruimao Biotechnology Co., Ltd.
Shaanxi Baohe Biotechnology Co., Ltd.
Shaanxi Lesent Biotechnology Co., Ltd.
Shaanxi Shuoyang Biotechnology Co., Ltd.
Shaanxi Mufan Biotechnology Co., Ltd.
Xi'an An'Drong Biomedical Technology Co., Ltd.
Shaanxi Guanchen Biotechnology Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bifidobacterium Longum Subsp. Infantis M-63 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bifidobacterium Longum Subsp. Infantis M-63, with price, sales quantity, revenue, and global market share of Bifidobacterium Longum Subsp. Infantis M-63 from 2020 to 2025.
Chapter 3, the Bifidobacterium Longum Subsp. Infantis M-63 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bifidobacterium Longum Subsp. Infantis M-63 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Bifidobacterium Longum Subsp. Infantis M-63 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bifidobacterium Longum Subsp. Infantis M-63.
Chapter 14 and 15, to describe Bifidobacterium Longum Subsp. Infantis M-63 sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Bifidobacterium Longum Subsp. Infantis M-63 Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 0-50 billion CFU/g
    • 1.3.3 50-100 billion CFU/g
    • 1.3.4 ＞100 billion CFU/g
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Bifidobacterium Longum Subsp. Infantis M-63 Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Food Additives
    • 1.4.3 Medicines and Supplements
    • 1.4.4 Feed Additives
    • 1.4.5 Others
  • 1.5 Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size & Forecast
    • 1.5.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity (2020-2031)
    • 1.5.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Mitushi Biopharma
    • 2.1.1 Mitushi Biopharma Details
    • 2.1.2 Mitushi Biopharma Major Business
    • 2.1.3 Mitushi Biopharma Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.1.4 Mitushi Biopharma Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Mitushi Biopharma Recent Developments/Updates
  • 2.2 Fengchen Group
    • 2.2.1 Fengchen Group Details
    • 2.2.2 Fengchen Group Major Business
    • 2.2.3 Fengchen Group Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.2.4 Fengchen Group Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Fengchen Group Recent Developments/Updates
  • 2.3 Jiangsu Wecare Biotechnology Co., Ltd.
    • 2.3.1 Jiangsu Wecare Biotechnology Co., Ltd. Details
    • 2.3.2 Jiangsu Wecare Biotechnology Co., Ltd. Major Business
    • 2.3.3 Jiangsu Wecare Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.3.4 Jiangsu Wecare Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Jiangsu Wecare Biotechnology Co., Ltd. Recent Developments/Updates
  • 2.4 Shenzhen Lefu Biotechnology Co., Ltd.
    • 2.4.1 Shenzhen Lefu Biotechnology Co., Ltd. Details
    • 2.4.2 Shenzhen Lefu Biotechnology Co., Ltd. Major Business
    • 2.4.3 Shenzhen Lefu Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.4.4 Shenzhen Lefu Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Shenzhen Lefu Biotechnology Co., Ltd. Recent Developments/Updates
  • 2.5 Hebei Hongtao Bioengineering Co., Ltd.
    • 2.5.1 Hebei Hongtao Bioengineering Co., Ltd. Details
    • 2.5.2 Hebei Hongtao Bioengineering Co., Ltd. Major Business
    • 2.5.3 Hebei Hongtao Bioengineering Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.5.4 Hebei Hongtao Bioengineering Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Hebei Hongtao Bioengineering Co., Ltd. Recent Developments/Updates
  • 2.6 Shandong Junle Biotechnology Co., Ltd.
    • 2.6.1 Shandong Junle Biotechnology Co., Ltd. Details
    • 2.6.2 Shandong Junle Biotechnology Co., Ltd. Major Business
    • 2.6.3 Shandong Junle Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.6.4 Shandong Junle Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Shandong Junle Biotechnology Co., Ltd. Recent Developments/Updates
  • 2.7 Shandong Xinxiong Biotechnology Co., Ltd.
    • 2.7.1 Shandong Xinxiong Biotechnology Co., Ltd. Details
    • 2.7.2 Shandong Xinxiong Biotechnology Co., Ltd. Major Business
    • 2.7.3 Shandong Xinxiong Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.7.4 Shandong Xinxiong Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Shandong Xinxiong Biotechnology Co., Ltd. Recent Developments/Updates
  • 2.8 Newgen Biotech
    • 2.8.1 Newgen Biotech Details
    • 2.8.2 Newgen Biotech Major Business
    • 2.8.3 Newgen Biotech Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.8.4 Newgen Biotech Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Newgen Biotech Recent Developments/Updates
  • 2.9 Pharm-Rx
    • 2.9.1 Pharm-Rx Details
    • 2.9.2 Pharm-Rx Major Business
    • 2.9.3 Pharm-Rx Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.9.4 Pharm-Rx Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Pharm-Rx Recent Developments/Updates
  • 2.10 Rajvi Enterprise
    • 2.10.1 Rajvi Enterprise Details
    • 2.10.2 Rajvi Enterprise Major Business
    • 2.10.3 Rajvi Enterprise Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.10.4 Rajvi Enterprise Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Rajvi Enterprise Recent Developments/Updates
  • 2.11 Shandong Pingao Pharmaceutical Co., Ltd.
    • 2.11.1 Shandong Pingao Pharmaceutical Co., Ltd. Details
    • 2.11.2 Shandong Pingao Pharmaceutical Co., Ltd. Major Business
    • 2.11.3 Shandong Pingao Pharmaceutical Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.11.4 Shandong Pingao Pharmaceutical Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Shandong Pingao Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.12 Shaanxi Chenming Biotechnology Co., Ltd.
    • 2.12.1 Shaanxi Chenming Biotechnology Co., Ltd. Details
    • 2.12.2 Shaanxi Chenming Biotechnology Co., Ltd. Major Business
    • 2.12.3 Shaanxi Chenming Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.12.4 Shaanxi Chenming Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Shaanxi Chenming Biotechnology Co., Ltd. Recent Developments/Updates
  • 2.13 Xi'an Minglang Biotechnology Co., Ltd.
    • 2.13.1 Xi'an Minglang Biotechnology Co., Ltd. Details
    • 2.13.2 Xi'an Minglang Biotechnology Co., Ltd. Major Business
    • 2.13.3 Xi'an Minglang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.13.4 Xi'an Minglang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Xi'an Minglang Biotechnology Co., Ltd. Recent Developments/Updates
  • 2.14 Jiahe Biotechnology (Shanxi) Co., Ltd.
    • 2.14.1 Jiahe Biotechnology (Shanxi) Co., Ltd. Details
    • 2.14.2 Jiahe Biotechnology (Shanxi) Co., Ltd. Major Business
    • 2.14.3 Jiahe Biotechnology (Shanxi) Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.14.4 Jiahe Biotechnology (Shanxi) Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Jiahe Biotechnology (Shanxi) Co., Ltd. Recent Developments/Updates
  • 2.15 Shaanxi Ruimao Biotechnology Co., Ltd.
    • 2.15.1 Shaanxi Ruimao Biotechnology Co., Ltd. Details
    • 2.15.2 Shaanxi Ruimao Biotechnology Co., Ltd. Major Business
    • 2.15.3 Shaanxi Ruimao Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.15.4 Shaanxi Ruimao Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Shaanxi Ruimao Biotechnology Co., Ltd. Recent Developments/Updates
  • 2.16 Shaanxi Baohe Biotechnology Co., Ltd.
    • 2.16.1 Shaanxi Baohe Biotechnology Co., Ltd. Details
    • 2.16.2 Shaanxi Baohe Biotechnology Co., Ltd. Major Business
    • 2.16.3 Shaanxi Baohe Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.16.4 Shaanxi Baohe Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Shaanxi Baohe Biotechnology Co., Ltd. Recent Developments/Updates
  • 2.17 Shaanxi Lesent Biotechnology Co., Ltd.
    • 2.17.1 Shaanxi Lesent Biotechnology Co., Ltd. Details
    • 2.17.2 Shaanxi Lesent Biotechnology Co., Ltd. Major Business
    • 2.17.3 Shaanxi Lesent Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.17.4 Shaanxi Lesent Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Shaanxi Lesent Biotechnology Co., Ltd. Recent Developments/Updates
  • 2.18 Shaanxi Shuoyang Biotechnology Co., Ltd.
    • 2.18.1 Shaanxi Shuoyang Biotechnology Co., Ltd. Details
    • 2.18.2 Shaanxi Shuoyang Biotechnology Co., Ltd. Major Business
    • 2.18.3 Shaanxi Shuoyang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.18.4 Shaanxi Shuoyang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Shaanxi Shuoyang Biotechnology Co., Ltd. Recent Developments/Updates
  • 2.19 Shaanxi Mufan Biotechnology Co., Ltd.
    • 2.19.1 Shaanxi Mufan Biotechnology Co., Ltd. Details
    • 2.19.2 Shaanxi Mufan Biotechnology Co., Ltd. Major Business
    • 2.19.3 Shaanxi Mufan Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.19.4 Shaanxi Mufan Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.19.5 Shaanxi Mufan Biotechnology Co., Ltd. Recent Developments/Updates
  • 2.20 Xi'an An'Drong Biomedical Technology Co., Ltd.
    • 2.20.1 Xi'an An'Drong Biomedical Technology Co., Ltd. Details
    • 2.20.2 Xi'an An'Drong Biomedical Technology Co., Ltd. Major Business
    • 2.20.3 Xi'an An'Drong Biomedical Technology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.20.4 Xi'an An'Drong Biomedical Technology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.20.5 Xi'an An'Drong Biomedical Technology Co., Ltd. Recent Developments/Updates
  • 2.21 Shaanxi Guanchen Biotechnology Co., Ltd.
    • 2.21.1 Shaanxi Guanchen Biotechnology Co., Ltd. Details
    • 2.21.2 Shaanxi Guanchen Biotechnology Co., Ltd. Major Business
    • 2.21.3 Shaanxi Guanchen Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product and Services
    • 2.21.4 Shaanxi Guanchen Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.21.5 Shaanxi Guanchen Biotechnology Co., Ltd. Recent Developments/Updates

3 Competitive Environment: Bifidobacterium Longum Subsp. Infantis M-63 by Manufacturer

  • 3.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue by Manufacturer (2020-2025)
  • 3.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Bifidobacterium Longum Subsp. Infantis M-63 by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Bifidobacterium Longum Subsp. Infantis M-63 Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Bifidobacterium Longum Subsp. Infantis M-63 Manufacturer Market Share in 2024
  • 3.5 Bifidobacterium Longum Subsp. Infantis M-63 Market: Overall Company Footprint Analysis
    • 3.5.1 Bifidobacterium Longum Subsp. Infantis M-63 Market: Region Footprint
    • 3.5.2 Bifidobacterium Longum Subsp. Infantis M-63 Market: Company Product Type Footprint
    • 3.5.3 Bifidobacterium Longum Subsp. Infantis M-63 Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size by Region
    • 4.1.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Consumption Value by Region (2020-2031)
    • 4.1.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Average Price by Region (2020-2031)
  • 4.2 North America Bifidobacterium Longum Subsp. Infantis M-63 Consumption Value (2020-2031)
  • 4.3 Europe Bifidobacterium Longum Subsp. Infantis M-63 Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Consumption Value (2020-2031)
  • 4.5 South America Bifidobacterium Longum Subsp. Infantis M-63 Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Bifidobacterium Longum Subsp. Infantis M-63 Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Type (2020-2031)
  • 5.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Consumption Value by Type (2020-2031)
  • 5.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Application (2020-2031)
  • 6.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Consumption Value by Application (2020-2031)
  • 6.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Type (2020-2031)
  • 7.2 North America Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Application (2020-2031)
  • 7.3 North America Bifidobacterium Longum Subsp. Infantis M-63 Market Size by Country
    • 7.3.1 North America Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Bifidobacterium Longum Subsp. Infantis M-63 Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Type (2020-2031)
  • 8.2 Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Application (2020-2031)
  • 8.3 Europe Bifidobacterium Longum Subsp. Infantis M-63 Market Size by Country
    • 8.3.1 Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Bifidobacterium Longum Subsp. Infantis M-63 Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Market Size by Region
    • 9.3.1 Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Type (2020-2031)
  • 10.2 South America Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Application (2020-2031)
  • 10.3 South America Bifidobacterium Longum Subsp. Infantis M-63 Market Size by Country
    • 10.3.1 South America Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Bifidobacterium Longum Subsp. Infantis M-63 Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Bifidobacterium Longum Subsp. Infantis M-63 Market Size by Country
    • 11.3.1 Middle East & Africa Bifidobacterium Longum Subsp. Infantis M-63 Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Bifidobacterium Longum Subsp. Infantis M-63 Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Bifidobacterium Longum Subsp. Infantis M-63 Market Drivers
  • 12.2 Bifidobacterium Longum Subsp. Infantis M-63 Market Restraints
  • 12.3 Bifidobacterium Longum Subsp. Infantis M-63 Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Bifidobacterium Longum Subsp. Infantis M-63 and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Bifidobacterium Longum Subsp. Infantis M-63
  • 13.3 Bifidobacterium Longum Subsp. Infantis M-63 Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Bifidobacterium Longum Subsp. Infantis M-63 Typical Distributors
  • 14.3 Bifidobacterium Longum Subsp. Infantis M-63 Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Bifidobacterium Longum Subsp. Infantis M-63. Industry analysis & Market Report on Bifidobacterium Longum Subsp. Infantis M-63 is a syndicated market report, published as Global Bifidobacterium Longum Subsp. Infantis M-63 Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Bifidobacterium Longum Subsp. Infantis M-63 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo